Upstream Bio (UPB) Gross Margin (2024 - 2025)
Upstream Bio (UPB) has 2 years of Gross Margin data on record, last reported at 272.18% in Q3 2025.
- For Q3 2025, Gross Margin fell 1320.0% year-over-year to 272.18%; the TTM value through Sep 2025 reached 522.76%, changed N/A, while the annual FY2024 figure was 177.64%, 13591.0% down from the prior year.
- Gross Margin reached 272.18% in Q3 2025 per UPB's latest filing, up from 967.24% in the prior quarter.
- Across five years, Gross Margin topped out at 45.16% in Q1 2024 and bottomed at 967.24% in Q2 2025.